Aditi Pharmaceuticals

Solapur, India Founded: 1987 • Age: 39 yrs
Specializes in contract manufacturing of sterile pharmaceutical products like injections and ampoules.

About Aditi Pharmaceuticals

Aditi Pharmaceuticals is a Healthcare company based in Solapur (India) founded in 1987. It specializes in contract manufacturing of sterile pharmaceutical products like injections and ampoules. It operates on a B2B model. The company has 103 employees. Its Indian entity Aditi Pharmaceuticals Pvt Ltd reported revenue of β‚Ή14.54 Cr. Its focus areas include Pharmaceuticals, Manufacturing and Sterile Products.

Company details

Aditi Pharmaceuticals specializes in contract manufacturing of sterile pharmaceutical products like injections and ampoules through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and sterile products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

  • Headquarters Solapur, India
  • Employees 103
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website aditipharma.com
  • Legal Name Aditi Pharmaceuticals Pvt Ltd
  • Date of Incorporation 07 May, 1985
  • Jurisdiction Solapur, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹14.54 Cr

    FY 2025 · -8% YoY

  • Net Profit
    ₹46.5 Lakh

    FY 2025 · 3% margin

  • EBITDA
    ₹94 Lakh

    FY 2025 · 6% margin

  • Employee Count
    103

Board of directors of Aditi Pharmaceuticals Pvt Ltd (Aditi Pharmaceuticals)

Aditi Pharmaceuticals Pvt Ltd is the primary company behind Aditi Pharmaceuticals. The board of Aditi Pharmaceuticals Pvt Ltd currently have 2 directors; the longest-serving is Atul Shantilal Bakshi, appointed in 1985. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Atul Shantilal Bakshi
DIN 00193201
Managing Director07 May 198541 yrs 5 moAditi Pharmaceuticals Pvt Ltd
Jemini Atul Bakshi
DIN 01810253
Director03 Oct 200719 yrs 1 moAditi Pharmaceuticals Pvt Ltd

Financials of Aditi Pharmaceuticals

Figures of Aditi Pharmaceuticals Pvt Ltd, the primary company behind Aditi Pharmaceuticals, for FY 2025. Revenue was ₹14.54 Cr (-8% year on year). Net profit was ₹46.5 Lakh (3% margin). EBITDA was ₹94 Lakh (6% margin). Revenue has grown at a compounded annual rate of -1% over three years and -2% over five years.

  • ₹14.54 CrRevenue · FY 2025 · -8% YoY
  • ₹46.5 LakhNet profit · 3% margin
  • ₹94 LakhEBITDA · 6% margin
  • ₹1.12 CrPaid-up capital
  • 103Employees (provident fund records)
  • -1%Revenue CAGR, 3 years
  • -2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Aditi Pharmaceuticals Pvt Ltd are on its company page.

Premium access

Detailed financial statements for Aditi Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Aditi Pharmaceuticals

Aditi Pharmaceuticals was founded in 1987.

Aditi Pharmaceuticals is headquartered in Solapur, India. It is registered at Solapur, Maharashtra, India.

Aditi Pharmaceuticals has 103 employees.

The primary company behind Aditi Pharmaceuticals, Aditi Pharmaceuticals Pvt Ltd, reported revenue of β‚Ή14.54 Cr for FY 2025, down 8% year on year.

Aditi Pharmaceuticals specializes in contract manufacturing of sterile pharmaceutical products like injections and ampoules through providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and sterile products. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.

Aditi Pharmaceuticals operates through Aditi Pharmaceuticals Pvt Ltd.

The legal entities of Aditi Pharmaceuticals currently have 2 directors, including Jemini Atul Bakshi, Atul Shantilal Bakshi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available